Skip to main content
58°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
9
Next >
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
Tickers
CRSP
EDIT
GILD
GNOM
Tags
MYGN
EDIT
GILD
From
InvestorPlace
Thinking of Buying Biotech Stocks? Do These 3 Things First
March 22, 2023
Tickers
CRSP
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Editas Medicine Earnings Preview
February 21, 2023
Tickers
EDIT
Tags
Market News
EDIT
Benzinga
From
Benzinga
These 2 Biotech Stocks Could Soar in the Next Bull Market
February 17, 2023
Tickers
CRSP
EDIT
Tags
CRSP
EDIT
Market News
From
Motley Fool
Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?
February 16, 2023
Tickers
EDIT
EXAS
Tags
Recent Press Releases
EDIT
Market News
From
Motley Fool
3 No-Brainer Stocks to Buy Right Now for Less Than $25
February 04, 2023
Tickers
EDIT
EXEL
IRWD
Tags
IRWD
Market News
EDIT
From
Motley Fool
Why Editas Medicine's Shares Jumped This Week
February 03, 2023
Tickers
CRSP
EDIT
VRTX
Tags
Market News
EDIT
VRTX
From
Motley Fool
Is Editas Medicine Stock a Buy Now?
February 03, 2023
Tickers
CRSP
EDIT
VRTX
Tags
CRSP
VRTX
EDIT
From
Motley Fool
3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later
February 02, 2023
Tickers
CRSP
EDIT
TXG
Tags
EDIT
CRSP
NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:TXG
From
InvestorPlace
Why Editas Medicine Stock Charged Higher in January
February 02, 2023
Tickers
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
February 01, 2023
Tickers
CRSP
EDIT
NTLA
Tags
Market News
Initiation
Analyst Color
From
Benzinga
Expert Ratings for Editas Medicine
February 01, 2023
Tickers
EDIT
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Tickers
AEP
AMD
APPS
AQUA
Tags
BZI/Ratings
GIS
Analyst Ratings
From
Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
Tickers
BEAM
BIIB
CLLS
CRSP
Tags
Stocks to Buy
Market News
CLLS
From
InvestorPlace
Why Shares of Editas Medicine Jumped This Week
January 26, 2023
Tickers
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
Shoreline Biosciences Acquires Editas' iNK Cell Franchise, Related Gene Editing Technologies
January 19, 2023
Tickers
EDIT
Tags
Benzinga
General
EDIT
From
Benzinga
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
January 18, 2023
Tickers
CRSP
EDIT
GNOM
Tags
Market News
EDIT
GNOM
From
InvestorPlace
Analyst Expectations for Editas Medicine's Future
January 10, 2023
Tickers
EDIT
Tags
EDIT
Market News
Benzinga
From
Benzinga
Why Editas Medicine Stock Is Sliding Today
January 09, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 08, 2022
Tickers
ALLO
BMY
CRBU
CRSP
Tags
Partner Content
GILD
EDIT
From
Benzinga
Analyst Ratings for Editas Medicine
December 06, 2022
Tickers
EDIT
Tags
EDIT
Market News
Analyst Ratings
From
Benzinga
2 Beaten-Down Stocks to Watch Closely Next Year
December 06, 2022
Tickers
BTAI
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Editas Medicine Touts Positive Safety, Efficacy Data From Two Sickle Cell Disease Patients
December 06, 2022
Tickers
EDIT
Tags
Briefs
Biotech
General
From
Benzinga
Why Shares of Editas Medicine Dropped 15.5% in November
December 05, 2022
Tickers
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
Where Will Editas Medicine Be in 1 Year?
November 20, 2022
Tickers
BLUE
CRSP
EDIT
Tags
BLUE
CRSP
EDIT
From
Motley Fool
Gene Editing Stock's Prospects Cut In Half By Analyst, Citing Limited Value In Retina Treatment
November 18, 2022
Tickers
EDIT
Tags
News
Market News
Downgrades
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Tickers
ABBV
AKLI
AMAT
AMGN
Tags
DPZ
AKLI
DLB
From
Benzinga
Palo Alto To Surge Around 38%? Plus This Analyst Predicts $65 For Helmerich & Payne
November 18, 2022
Tickers
AMAT
BABA
EDIT
HP
Tags
Analyst Ratings
AMAT
BABA
From
Benzinga
Intuit To $490? Here Are 5 Other Price Target Changes For Friday
November 18, 2022
Tickers
EDAP
EDIT
INTU
JACK
Tags
News
JACK
EDAP
From
Benzinga
Gap To Rally 18%? Plus This Analyst Slashes PT On Super League Gaming By 50%
November 18, 2022
Tickers
EDIT
GLOB
GPS
GTLS
Tags
Pre/Market Outlook
GTLS
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
